Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism
In this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrot...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2021/7618166 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550869741076480 |
|---|---|
| author | Yan Wang Yanlei Sun Fengli Shao Bo Zhang Zhen Wang Xinpeng Li |
| author_facet | Yan Wang Yanlei Sun Fengli Shao Bo Zhang Zhen Wang Xinpeng Li |
| author_sort | Yan Wang |
| collection | DOAJ |
| description | In this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrotic symptoms and collagen deposition. Immunohistochemistry and western blot analyses indicated that the diabetic condition significantly increased the expressions of fibrotic markers including collagen, α-SMA, and fibronectin. The levels of cholesterol, triglyceride, and low-density lipoprotein were also increased in diabetic kidney disease (DKD) rat blood, while the level of high-density lipoprotein was decreased. The results of Oil red O staining experiments indicated that the kidneys of diabetic rats exhibited appreciable fat deposition, with high contents of triglyceride and cholesterol. To inhibit fibrosis and reduce fat deposition, low molecular weight fucoidan (LMWF) may be used. Based on PCR and western blot analyses, LMWF can regulate the expression levels of important lipid metabolism regulators, thereby impeding the development of kidney fibrosis. Through the vitro model, it also be indicated that LMWF could inhibit fibrosis process through regulating lipid metabolism which induced by palmitic acid. |
| format | Article |
| id | doaj-art-de7d0c999fd14583bf24620868866e53 |
| institution | Kabale University |
| issn | 2314-6753 |
| language | English |
| publishDate | 2021-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-de7d0c999fd14583bf24620868866e532025-02-03T06:05:44ZengWileyJournal of Diabetes Research2314-67532021-01-01202110.1155/2021/7618166Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid MetabolismYan Wang0Yanlei Sun1Fengli Shao2Bo Zhang3Zhen Wang4Xinpeng Li5College of PharmacyLinyi Tumor HospitalCollege of Life SciencesCollege of PharmacyCollege of PharmacyCollege of PharmacyIn this study, a diabetic kidney disease model was established by placing the test rats on a high-sugar/high-fat diet combined with streptozotocin induction. Histopathological examination (H&E, Masson, and PASM stain) showed pathological changes in the diabetic rat kidneys, in addition to fibrotic symptoms and collagen deposition. Immunohistochemistry and western blot analyses indicated that the diabetic condition significantly increased the expressions of fibrotic markers including collagen, α-SMA, and fibronectin. The levels of cholesterol, triglyceride, and low-density lipoprotein were also increased in diabetic kidney disease (DKD) rat blood, while the level of high-density lipoprotein was decreased. The results of Oil red O staining experiments indicated that the kidneys of diabetic rats exhibited appreciable fat deposition, with high contents of triglyceride and cholesterol. To inhibit fibrosis and reduce fat deposition, low molecular weight fucoidan (LMWF) may be used. Based on PCR and western blot analyses, LMWF can regulate the expression levels of important lipid metabolism regulators, thereby impeding the development of kidney fibrosis. Through the vitro model, it also be indicated that LMWF could inhibit fibrosis process through regulating lipid metabolism which induced by palmitic acid.http://dx.doi.org/10.1155/2021/7618166 |
| spellingShingle | Yan Wang Yanlei Sun Fengli Shao Bo Zhang Zhen Wang Xinpeng Li Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism Journal of Diabetes Research |
| title | Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism |
| title_full | Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism |
| title_fullStr | Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism |
| title_full_unstemmed | Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism |
| title_short | Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism |
| title_sort | low molecular weight fucoidan can inhibit the fibrosis of diabetic kidneys by regulating the kidney lipid metabolism |
| url | http://dx.doi.org/10.1155/2021/7618166 |
| work_keys_str_mv | AT yanwang lowmolecularweightfucoidancaninhibitthefibrosisofdiabetickidneysbyregulatingthekidneylipidmetabolism AT yanleisun lowmolecularweightfucoidancaninhibitthefibrosisofdiabetickidneysbyregulatingthekidneylipidmetabolism AT fenglishao lowmolecularweightfucoidancaninhibitthefibrosisofdiabetickidneysbyregulatingthekidneylipidmetabolism AT bozhang lowmolecularweightfucoidancaninhibitthefibrosisofdiabetickidneysbyregulatingthekidneylipidmetabolism AT zhenwang lowmolecularweightfucoidancaninhibitthefibrosisofdiabetickidneysbyregulatingthekidneylipidmetabolism AT xinpengli lowmolecularweightfucoidancaninhibitthefibrosisofdiabetickidneysbyregulatingthekidneylipidmetabolism |